Keywords: xeloda, avastin, get, expanded, indications, european, medicines

Xeloda and Avastin to get expanded indications

Article | 24 December 2007

The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has adopted a label extension for Roche's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in